Financial comparisons WuXi Biologics (Cayman) Inc. OTC Markets
Stocks
WXXWY
US98260N1081
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.610 USD | -2.56% |
|
+0.13% | -4.88% |
| 02:12am | CANbridge Pharmaceuticals Enters Service Agreements With WuXi Biologics, Baheal Medical | MT |
| Jun. 05 | Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 4.23B | 30.41% | 24.81% | 20.15% | 17.36% | -3.18x | |
| 6.5B | 42.13% | 52.64% | 28.56% | 20.88% | -0.99x | |
| 3.37B | -39.59% | -48.95% | -5.88% | -5.1% | 6.99x | |
| 606M | -210.54% | -205.59% | -249.28% | - | 0.72x | |
| 3.69B | 25.89% | 28.63% | 17.53% | 9.99% | -1.51x | |
| 2.32B | 33.73% | 37.59% | 35.53% | 27.02% | -1.18x | |
| 294M | -18.56% | -24.05% | -9.34% | -9.05% | 8.22x | |
| 958M | -30.08% | -31.31% | -42.49% | - | 2.15x | |
| 498M | 32.27% | 31.52% | 16.97% | 14.74% | -3.83x | |
| 829M | -0.2% | 11.86% | -0.5% | - | -6.61x | |
| 437M | -36.42% | -29.57% | -7.45% | -4.07% | 6.67x | |
| 88.04M | -891.6% | -695.44% | - | -55.55% | 0.05x | |
| 463M | 21.89% | 22.29% | 25.37% | 11.13% | 2.45x | |
| 113M | -310.18% | -226% | - | - | - | |
| 1.16B | 23.46% | 22.49% | 20.46% | 11.16% | 0.73x | |
| Average | 1.7B | -88.49% | -68.61% | -11.57% | 3.5% | 0.76x | |
| Weighted average by Cap. | 2.85B | -48.14% | -37.18% | -9.81% | 8.95% | 0.09x |
- Stock Market
- Stocks
- 2269 Stock
- WXXWY Stock
- Sector WuXi Biologics (Cayman) Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
